FAIR VALUE MEASUREMENTS (Tables)

6 Months Ended

Apr. 30, 2023

Fair Value Assets And Liabilities Measured On Recurring Basis

Financial assets and liabilities measured at fair value on a recurring basis as of April 30, 2023 were as follows:


			Fair Value Measurement at April 30, 2023 Using
	April 30, 2023		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in millions)
Assets:
Short-term
Cash equivalents (money market funds)	$	526	$	526	$	—	$	—
Derivative instruments (foreign exchange contracts)	13		—		13		—

Long-term
Trading securities	37		37		—		—
Other investments	28		—		28		—

Total assets measured at fair value	$	604	$	563	$	41	$	—
Liabilities:
Short-term
Derivative instruments (foreign exchange contracts)	$	11	$	—	$	11	$	—
Contingent consideration	7		—		—		7
Long-term
Deferred compensation liability	37		—		37		—
Contingent consideration	1		—		—		1
Total liabilities measured at fair value	$	56	$	—	$	48	$	8

Financial assets and liabilities measured at fair value on a recurring basis as of October 31, 2022 were as follows:


			Fair Value Measurement at October 31, 2022 Using
	October 31, 2022		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
	(in millions)
Assets:
Short-term
Cash equivalents (money market funds)	$	492	$	492	$	—	$	—
Derivative instruments (foreign exchange contracts)	31		—		31		—

Long-term
Trading securities	31		31		—		—
Other investments	23		—		23		—
Total assets measured at fair value	$	577	$	523	$	54	$	—
Liabilities:
Short-term
Derivative instruments (foreign exchange contracts)	$	5	$	—	$	5	$	—
Contingent consideration	66		—		—		66
Long-term
Deferred compensation liability	31		—		31		—
Contingent consideration	1		—		—		1
Total liabilities measured at fair value	$	103	$	—	$	36	$	67

Gain (Loss) on Securities

Gains and losses reflected in other income (expense), net for our equity investments with readily determinable fair value ("RDFV") and equity investments without RDFV are summarized below:



	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2023		2022		2023		2022
	(in millions)
Net loss recognized during the period on equity securities	$	4	$	15	$	14	$	62
Less: Net loss on equity securities sold during the period	$	4	$	—	$	15	$	—
Unrealized (gain) loss on equity securities	$	—	$	15	$	(1)	$	62

Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The contingent consideration liability is our only recurring Level 3 asset or liability. A summary of the Level 3 activity follows:


	Three Months Ended				Six Months Ended
	April 30,				April 30,
	2023		2022		2023		2022
	(in millions)
Beginning balance	$	3	$	92	$	67	$	89
Additions to contingent consideration (including measurement period adjustment)	$	5	$	3	$	5	$	3
Payments	$	—	$	—	$	(65)	$	—
Change in fair value (included within selling, general and administrative expenses)	$	—	$	(28)	$	1	$	(25)
Ending balance	$	8	$	67	$	8	$	67